Considerations When Evaluating eCTD Submission Publishing and Management Vendors
Getting your product’s regulatory submission ready to send to the FDA, Health Canada, or European health authorities can be...
top of page
We Are Your Solution
Search
- Nov 15, 2022
- 5 min
PDUFA: 30 Years and Counting
The Prescription Drug User Fee Act (PDUFA) was signed into law in 1992 by George H. W. Bush, as an amendment to the Federal Food, Drug,...
43 views0 comments
- Oct 6, 2022
- 4 min
Should Small Pharma and Biotech Companies Build Regulatory Operations Capabilities?
Small pharmaceutical and biotech companies that are preparing to submit their first Investigational New Drug Application (IND) must make...
89 views0 comments
- Aug 15, 2022
- 4 min
FDA Resources to Support Your Next eCTD Submission
The U.S. FDA has published numerous resources that teams can access to understand the requirements for a submission in electronic Common...
82 views0 comments
- Apr 28, 2022
- 4 min
Ad Promo Series: Using Grouped Submissions for Multi-Product Advertising Materials
Introduction In 2015, the concept of grouped submissions was introduced with the implementation of the US Module 1 specification v3.3....
125 views0 comments
- Apr 18, 2022
- 1 min
Updates to the FDA’s Ad Promo Guidance
The FDA ad promo guidance, Providing Regulatory Submissions in Electronic and Non-Electronic Format — Promotional Labeling and...
101 views0 comments
- Feb 21, 2022
- 1 min
eCTD Module 1 Specification Reminder
O March 1, 2022, the US FDA will no longer be accepting the eCTD Module 1 specification v1.3 (US regional DTD v2.01)
107 views0 comments
- Apr 6, 2021
- 5 min
The Basics of BIMO
Introduction If you have submitted an initial marketing application in the US over the past few years, you may have included a BIMO data...
1,549 views0 comments
- Jul 22, 2020
- 3 min
FDA Ad-Promo Series: 2253 Submissions in eCTD Format
WAYS describes the documentation required for 2253 submissions in eCTD format
1,151 views0 comments
- Apr 29, 2020
- 4 min
Compiling US Orphan Drug Designation Requests
In the United States, the Orphan Drug Act (ODA) was passed in 1983 to facilitate the development of drugs or biologics that are used for the
1,010 views0 comments
- Mar 19, 2020
- 3 min
eCTD Guidance Updates – What’s New in 2020
FDA has released several updates to eCTD Guidances
276 views0 comments
- Jan 23, 2020
- 5 min
Simultaneous US/EU Submissions: 5 Tips for Success
Introduction The US NDA and EU MAA applications are complex projects that take careful strategic planning and time management. The two...
182 views0 comments
- Nov 4, 2019
- 6 min
Annual Registration Renewals: Ensuring Compliance to Avoid Inactivation
Every year, from October 1st to December 31st , sponsors are required to renew their Establishment Registrations with FDA, as well as...
36 views0 comments
- Oct 24, 2019
- 3 min
Drug Master Files: Highlights of the Updated FDA Guidance
On October 18, 2019, FDA released an updated draft Guidance regarding Drug Master Files (DMFs) titled “Drug Master Files Guidance for...
529 views0 comments
- Oct 3, 2019
- 2 min
New Draft FDA Guidance: Electronic Format for Medical Device Submissions
On September 26, 2019, the FDA released a new draft guidance document titled “Providing Regulatory Submissions for Medical Devices in...
184 views0 comments
- Sep 6, 2019
- 4 min
FDA Ad-Promo Series: Navigating eCTD Submissions for Accelerated Approval Products
Background on Subpart H/E Products For life-threatening diseases where there is no current marketed treatment, the FDA may allow for an...
452 views0 comments
- Jul 31, 2019
- 2 min
FDA Ad-Promo Series: The Guidance Has Been Finalized – What’s Next For Sponsors?
On June 21, 2019, FDA released the Finalized Guidance for Promotional Labeling and Advertising Materials for Human Prescription Drugs....
77 views0 comments
"WAYS OF WORKING" BLOG
bottom of page